Day 2Structural heart diseaseValvular Aortic valve

SOLACI-SOCIME 2018 | TAVI in a low risk patients

solaci
solaci
663
0

Dr. Jose María HernándezRead articles on the main presentations of the first day of SOLACI-SOCIME 2018 Congress.

See the presentation by Dr. José María Hernández, entitled “TAVI in a low risk patients”.

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

Previous article
SOLACI-SOCIME 2018 | Usefulness of the functional evaluation with iFR and FFR in bifurcations to define PCI
Next article
SOLACI-SOCIME 2018 | Justification of PCI for Coronary Chronic Total Occlusion
solaci
solaci

More articles by this author

Hemodynamic Outcomes of Edge-to-Edge Repair in Degenerative and Functional Mitral Regurgitation

Dr. Andrés Rodríguez - 0
Transcatheter edge-to-edge mitral valve repair (M-TEER) has become an established therapeutic option for mitral valve disease. Among the available techniques, M-TEER using the MitraClip...

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

Dr. Omar Tupayachi - 0
The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

Inflammation after TAVI: An Emerging Therapeutic Target?

Dr. Juan Manuel Pérez - 0
Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Dr. Omar Tupayachi - 0
Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Mitral valve

Hemodynamic Outcomes of Edge-to-Edge Repair in Degenerative and Functional Mitral Regurgitation

Transcatheter edge-to-edge mitral valve repair (M-TEER) has become an established therapeutic option for mitral valve disease. Among the available techniques,...
Dr. Andrés Rodríguez -
SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Dr. Juan Manuel Pérez - 0
Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...

Dual-Prep Registry: Atherectomy and IVL for Severe Coronary Calcification

Dr. Omar Tupayachi - 0
Severe coronary calcification remains one of the most challenging scenarios in percutaneous coronary intervention (PCI). Although rotational or orbital atherectomy and intravascular lithotripsy (IVL)...

Hemodynamic Outcomes of Edge-to-Edge Repair in Degenerative and Functional Mitral Regurgitation

Dr. Andrés Rodríguez - 0
Transcatheter edge-to-edge mitral valve repair (M-TEER) has become an established therapeutic option for mitral valve disease. Among the available techniques, M-TEER using the MitraClip...